Entry of the antipsychotic drug, olanzapine, into the developing rat brain in mono- and combination therapies [version 2; peer review: 2 approved]

Background: Olanzapine is used to treat schizophrenia and bipolar disorder in women of childbearing age. Continuation of psychotropic medications throughout pregnancy and lactation is often required as cessation could be dangerous for both mother and child. However, there is a lack of information on...

Full description

Bibliographic Details
Main Authors: Mark Habgood, Katarzyna Dziegielewska, Yifan Huang, Shuai Nie, Fiona Qiu, Norman Saunders
Format: Article
Language:English
Published: F1000 Research Ltd 2023-02-01
Series:F1000Research
Subjects:
Online Access:https://f1000research.com/articles/11-1417/v2